The Food and Drug Administration says it will remove a long-standing warning from hormone-based drugs used to treat menopause ...

In an interview with CBS News, FDA Commissioner Dr. Marty Makary explains what went into the decision to drop the most ...

In a sweeping reversal of two decades of medical caution, the U.S. Department of Health and Human Services (HHS) and the Food ...

Medical misinformation could cost lives, erode trust in healthcare, and fuel predatory marketing of unproven supplements or “cures.” ...

Traditionally, lung cancer is associated with older patients, specifically men who smoked. But doctors say that's beginning ...

Dr. Anthony Bashall of Franciscan Alliance touches on heart health for women going through menopause in our latest Women's ...

Gates is investing $100 million to focus on medical issues that have long-impacted women specifically — such as menopause, ...

Clinicians at Greater Baltimore Medical Center in Towson successfully reduced the number of mothers who suffered postpartum ...

Each week, we talk with Dr. Diana Bitner about new development's in women's health. She joins us from Sri Lanka to talk about ...

Evidence links the gut microbiota and fertility to women’s reproductive health, influencing hormone metabolism, and ...

FDA Commissioner Dr. Marty Makary makes an announcement about his agency’s intent to remove the “black box” warnings from hormone replacement therapy for menopause.

Early population studies, such as the seminal Framingham Heart Study, represented a moment of hope. However, initial analyses ...